Trial Profile
A Randomized, Open-Label, Single-Dose Study to Assess the Relative Bioavailability of LY03005 Oral Tablets Versus Pristiq Oral Tablets Under Fasting Conditions in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Toludesvenlafaxine (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Luye Pharma Group
- 17 Mar 2017 Status changed from recruiting to completed.
- 12 Dec 2016 New trial record